Pluristem Announces Agreement With Japan's PMDA on Design of Final Trial Needed to Apply for Conditional Approval of PLX-PAD
December 21, 2015 at 04:21 AM EST
Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that it has reached an agreement with Japan's Pharmaceuticals and Medical ...